About
Seth focuses on 8VC's Bio-IT investment area, backing companies spanning therapeutics, tools, bio-infrastructure and applications of biology. He previously worked in Amgen's business development technology group, at ZS Associates, and co-founded biologics startup Protomer Technologies as COO. He holds a Ph.D. in Biochemistry and Molecular Biophysics from Caltech and B.S./M.S. degrees in Biochemistry from Brandeis University.
Invests in
BiotechDeep Tech
Deals · 1
Tasca Therapeutics CorpBoard seat
via 8VC · filed Dec 2025 · $70.2M raise
Attribution from SEC filings, press coverage, and firm rosters.